Protide Pharmaceuticals Inc PPMD:OTCPK

RT Quote | Exchange | USD
Last | 02/18/21 EST
0.088UNCH (UNCH)
52 week range
0.09 - 0.28

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.088
  • 52 Week High0.28
  • 52 Week High Date02/09/21
  • 52 Week Low0.09
  • 52 Week Low Date02/18/21
  • Market Cap350,000.00
  • Shares Out4.03M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-4.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-60,000.00
  • ROE (MRQ)-30.44%
  • Revenue (MRQ)500,000.00
  • Gross Margin (MRQ)72.62%
  • Net Margin (MRQ)-17.06%
  • Debt To Equity (MRQ)29.71%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Protide Pharmaceuticals Inc News

There is no recent news for this security.

Latest PPMD News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Protide Pharmaceuticals, Inc. is engaged in the discovery, development and commercialization of technologies and processes in clinical cell therapy, regenerative medicine, transfusion medicine, cell engineering and transplantation. The Company offers products, such as VaxMax/Biologics Production Media, Cell Culture and Processing, Stem Cell Cryopreservatives, Stem Cell and Regenerative Research and CIT Islet Cell Solutions. The Company offers VaxMax 100X concentrate. The...
Milo Polovina
Chief Executive Officer
Address
220 Telser Rd
Lake Zurich, IL
60047-1525
United States